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high-frequency CES. In contrast, both groups showed an in-
crease in the level of cortisol after the 6-week treatment pe-
riod.  Conclusions: High-frequency CES appeared to be inef-
fective in AD patients. 
 
Copyright © 2006 S. Karger AG, Basel 
 In previous studies, transcutaneous electrical nerve 
stimulation, a type of peripheral nerve stimulation, ap-
peared to strengthen the coupling of the rest-activity 
rhythm to supposedly stable zeitgebers in patients with 
Alzheimer’s disease (AD)  [1, 2] . Moreover, AD patients 
showed a decrease in nocturnal restlessness. Another 
type of mild electrical stimulation that is partly mediated 
by the peripheral nervous system is cranial electrostimu-
lation (CES). It was observed that CES improved sleep 
quality after 2 weeks of treatment in older people with 
vascular dementia  [3] .
 Based on the positive effects mentioned above, we ex-
amined in a recent study the effects of low-frequency CES 
on the rest-activity rhythm and salivary cortisol of pa-
tients in a relatively early stage of AD  [4] . The motivation 
to apply particularly  low-frequency stimulation was that 
this type of stimulation preferably stimulates the locus 
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 Abstract 
 Objective: In a previous study, low-frequency (0.5 Hz) cra-
nial electrostimulation (CES) neither improved the rest-ac-
tivity rhythm nor reduced the level of salivary cortisol in pa-
tients with probable Alzheimer’s disease (AD). To investigate 
whether the frequency of CES was responsible for these neg-
ative findings, we set out to examine the effects of high-fre-
quency CES on the rest-activity rhythm and salivary cortisol 
of patients with probable AD. We hypothesized that a de-
creased level of cortisol would parallel a positive effect of 
high-frequency CES on nocturnal restlessness in AD pa-
tients.  Methods: Twenty AD patients were randomly as-
signed to an experimental group (n = 10) and a control group 
(n = 10). The experimental group was treated with high-fre-
quency CES, the control group received sham stimulation, 
for 30 min a day, during 6 weeks. The rest-activity rhythm 
was assessed by actigraphy. Level of cortisol was measured 
by means of salivette tubes.  Results: The rest-activity rhythm 
and the level of salivary cortisol did not react positively to 
 Accepted: March 15, 2006 
 Published online: August 15, 2006 
 Erik J.A. Scherder, PhD
Department of Human Movement Sciences
University of Groningen, A. Deusinglaan 1
NL–9713 AV Groningen (The Netherlands)
Tel. +313 50 363 2470, Fax +31 50 363 31, E-Mail e.j.a.scherder@rug.nl 
 © 2006 S. Karger AG, Basel
1420–8008/06/0224–0267$23.50/0 
 Accessible online at:
www.karger.com/dem 
 Scherder  /Knol  /van Tol  /van Someren  /
Deijen  /Swaab  /Scheltens  
Dement Geriatr Cogn Disord 2006;22:267–272268
coeruleus (LC)/noradrenergic neurotransmitter system 
 [5] , which strongly projects to the hypothalamic supra-
chiasmatic nucleus  [6] . Salivary cortisol was included as 
a dependent variable since an increased level of cortisol 
is indicative of a hyperactive hypothalamic-pituitary-ad-
renal axis which could cause sleeplessness  [7–9] . The re-
sults of that study  [4] showed that low-frequency CES did 
not improve the rest-activity rhythm in AD patients and 
did not lower the level of salivary cortisol. One explana-
tion might be that it is insufficient to focus treatment par-
ticularly on the LC/noradrenergic system whereas also 
other neurotransmitter systems are affected in AD, e.g. 
the serotonergic system that originates in the dorsal ra-
phe nucleus (DRN)  [10] . Both the LC/noradrenergic and 
the DRN/serotonergic system project to the basal fore-
brain cholinergic neurons  [11] and the basal forebrain 
cholinergic neurons project to the hypothalamic supra-
chiasmatic nucleus  [12] . It is of note that the LC and DRN 
not only project to the basal forebrain, they are also in-
nervated by the basal forebrain. Moreover, the LC and 
DRN receive projections from the hypothalamus  [12] . 
These mutual connections reflect an integrative system 
that plays an important role in circadian rhythms  [12] . 
Since the DRN/serotonergic system preferably responds 
to high-frequency stimulation  [13] and the LC/noradren-
ergic neurons are also able to react to high-frequency 
stimulation  [5] , the goal of the present study was to ex-
amine the effects of  high-frequency CES on the circadian 
rest-activity rhythm in patients with AD.
 Similar to the previous CES study in AD  [4] , also in 
the present study, it was examined whether the high level 
of cortisol, indicative of sleeplessness  [7–9] , would de-
crease by high-frequency CES.
 Materials and Methods 
 Participants 
 The sample consisted of 20 subjects, drawn from a sample of 
500 institutionalized elderly persons. All subjects met the 
NINCDS-ADRDA criteria for the clinical diagnosis of probable 
AD  [14] and were in stage 5 of the Global Deterioration Scale, in-
dicative of moderate to severe dementia  [15] . Exclusion criteria 
were a history of psychiatric disorder, alcoholism, cerebral trau-
ma, cerebrovascular disease, hydrocephalus, neoplasm, epilepsy, 
disturbances of consciousness, focal brain disorders, and a pace-
maker. Level of general cognitive functioning was measured by 
the Mini-Mental State Examination (MMSE), with a maximum 
score of 30  [16] . The level of education was quantified on a 5-point 
Likert-type scale (for details, see Scherder et al.  [4] ).
 Subjects were randomly assigned to an experimental group 
(n = 10) and a control group (n = 10). The gender of the experi-
mental group (10 women) and the gender of the control group
(8 females, 2 males) did not differ significantly (   2  = 2.22, d.f. = 1; 
n.s.). The mean age of the participants of the experimental group 
(83.70 years) did not differ significantly from the mean age of the 
control group (84.50 years) [t(18) = 0.38; n.s.]. The mean MMSE 
score of the experimental group (18.20) was not significantly dif-
ferent from the mean MMSE score of the control group (20) [t(18) 
= 0.98; n.s.]. There was no significant difference between the lev-
el of education of the experimental group (2.70) and the control 
group (3.30) [t(18) = 1.16; n.s.].
 The patients and their families were extensively informed 
about the aim and procedure of the study and gave their informed 
written consent to further participate in the study. Before onset 
of the treatment procedure, a trial treatment was applied to both 
the experimental and the control group. No negative reactions of 
the patients were observed. The patients and their relatives were 
not aware of the group in which they participated (experimental 
or control group), thus preventing a possible bias. The local Med-
ical Ethics Committee approved the study.
 Assessment of the Circadian Rhythms 
 The Rest-Activity Rhythm  
 The circadian rest-activity rhythm was assessed noninvasively 
by an actigraph (Actiwatch, Cambridge Neurotechnology, Cam-
bridge, UK), 24 h a day, for 1 week. The actigraph has the size and 
shape of a watch, is worn on the dominant wrist, and registers ac-
celeration-induced wrist movements. The actigraph quantifies ac-
celerations due to motor activity of the arm and integrates these 
over 1-min periods. From the resulting rest-activity rhythms, 3 
nonparametric variables were calculated  [17] , using the Actiwatch 
Sleep Analysis 2001 software (Cambridge Neurotechnology):
(1) interdaily stability (IS), a variable that quantifies the strength 
of coupling between the rest-activity rhythm and supposedly sta-
ble zeitgebers (e.g. meals); (2) intradaily variability (IV), a variable 
that quantifies the fragmentation of the rhythm, that is, the fre-
quency and extent of transitions between rest and activity, and 
(3) relative amplitude (RA), a variable that quantifies the differ-
ence between the main activity (day) and rest (night) periods.
 Salivary Cortisol Measurement  
 Results of several studies suggest that salivary cortisol is a reli-
able reflection of cortisol concentrations in blood  [18, 19] . It rep-
resents cortisol that is not bound to plasma proteins, and, there-
fore, reflects the biologically active free hormone concentration. 
Salivary cortisol concentrations were obtained by means of 
salivette tubes (Sarstedt, Rommelsdorf, Germany). The partici-
pants were asked to chew on a cotton-wool swab for about 1 min, 
which is sufficient to collect enough material for analyses  [19] . 
Sampling took place at 9 different points during 24 h. The first 
sample took place immediately after the moment of awakening, 
the final sample was acquired just before the patient went to sleep; 
for further information about the specific points, see Scherder et 
al.  [4] . All saliva sampling was conducted between 7:  28 AM and 
11:  00 PM. Because the duration of the study was 2 years and the 
patients were randomly assigned to both groups in parallel, sea-
son effects can be disregarded.
 Cortisol Analysis  
 Salivary cortisol was analyzed by a coated-tube radioimmu-
noassay with the Orion Diagnostica Spectra Cortisol Ria Test 
(Orion Corporation Orion Diagnostica, Espoo, Finland).
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 Procedure 
 Treatment  
 CES was applied by the AlphaStim 100, in exactly the same 
way as in the former low-frequency study  [4] . The only difference 
between both studies was the stimulation frequency: 100 Hz 
(high-frequency) in the present study versus 0.5 Hz (low-frequen-
cy) in the former one. Participants were (sham) stimulated for a 
period of 6 weeks, 5 days a week, for 30 min each day. For further 
details, see Scherder et al.  [4] .
 Moments of Measurement  
 The actigraph and cortisol measurements took place before 
the 6-week treatment period with (sham) CES (pre), after the 6-
week treatment period (post), and again after a treatment-free 
period of 6 weeks (delayed).
 Statistical Analyses 
 Actigraphy  
 Multivariate analyses of variance (MANOVAs) with group 
(treatment and control group) as an independent factor and time 
[3 levels, i.e. pretreatment: T1; post-treatment: T2, and after a treat-
ment-free period (delayed): T3] as a repeated-measures factor were 
used to analyze the actigraphic variables. In view of the explorative 
character of this pilot study, data were submitted to interaction F 
statistics with 1 degree of freedom on the contrasts T1-T2, T2-T3, 
and T1-T3, even when the MANOVAs yielded no significant inter-
actions between group and time. If significant interactions oc-
curred concerning one or more contrasts, paired within-group
t tests would be performed. This appeared not to be the case in the 
present study (see the Results section). Effect sizes (   2 ) were calcu-
lated, that is small  ! 0.01, medium  ! 0.6, and large  6 0.14.
 The Bonferroni correction was applied to the significance lev-
el of p  ! 0.05, resulting in a critical value of p  ! 0.01. The SPSS-PC 
program  [20] was used to analyze the data.
 Salivary Cortisol Measurements  
 The (at most) 27 cortisol measures per person were obtained 
at irregular times between 7.28 AM and 11.00 PM, which makes 
a repeated-measures analysis of variance inapplicable. In order to 
model the cortisol values as a periodic function of the time of 
measurement, multilevel analysis  [21] was used in the same way 
as in the previous study  [4] . An advantage of the multilevel mod-
elling is that missing data can be dealt with in a rather easy way. 
In our data set, we have 473 measurements from the maximum of 
540:  27 (9 samples at pretreatment, post-treatment, and delayed 
measurement)  ! 20 (10 patients in the experimental group, 10 
patients in the control group). A second advantage of multilevel 
modelling is that we can model the daily (24-hour) cyclical pat-
tern of cortisol measures  [22] .
 For a detailed description of the multilevel two-harmonics 
models to fit the cortisol level of the experimental group and the 
control group, we refer to the previous low-frequency CES study 
 [4] . 
 Results 
 Effects of CES on the Rest-Activity Rhythm 
 Repeated-measures MANOVAs did not reveal signifi-
cant group  ! time interaction effects for IS [F(2, 18) = 
0.88, p = 0.43], IV [F(2, 18) = 3.18, p = 0.07], and RA [F(2, 
18) = 2.63, p = 0.10]. Means and standard deviations are 
presented in  table 1 .Interaction F  statistics with 1 degree 
of freedom did not show any significant difference be-
tween both groups after the treatment period, i.e. the con-
trast T1-T2 (pre-post) ( table 1 ).
 Effects of CES on Salivary Cortisol 
 Since the data were not normally distributed, the mul-
tilevel model was fitted to the log-transformed data. The 
parameter estimates of the interaction model are shown 
in  table 2 . Data analyses showed that there was no sig-
nificant interaction effect between group and time, in-
cluding group  ! post-treatment (T2) and group  ! de-
layed measurement (T3) (likelihood ratio    2  = 3.32, d.f. = 
2, p = 0.19). Because the group  ! time interaction was 
not significant, the model was also fitted without interac-
tion. The parameter estimates of this model are also 
shown in  table 2 (no interaction model). The back-trans-
formed mean cortisol curves are shown in  figure 1 , and 
the  mean  cortisol  values  evaluated  at value 0 (at about 
11:  00 AM) of the periodic function are shown in  table 3 . 
As can be seen in  figure 1 , the minimum cortisol level of 
3.51 nmol/l occurred at about 9.39 PM (control group, 
delayed measurement), whereas the projected maximum 
Table 1. Means, standard deviations, and analyses of variance of the three actigraphy variables
Actig-
raphy
Experimental group Control group ANOVA (T1-T2) Effect
size
2pre post del pre post del F (1, 19) p
mean SD mean SD mean SD mean SD mean SD mean SD
IS 0.63 0.14 0.64 0.12 0.59 0.20 0.65 0.16 0.59 0.18 0.62 0.08 0.86 0.37 0.043
IV 1.16 0.19 1.18 0.21 1.28 0.27 1.31 0.32 1.34 0.27 1.15 0.15 0.006 0.94 0.000
RA 0.78 0.09 0.79 0.08 0.77 0.08 0.77 0.14 0.80 0.12 0.83 0.09 0.20 0.66 0.01
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 Fig. 1. The fitted multilevel model for the 
mean values of saliva cortisol of the exper-
imental and control group between 7:  00 
AM and 11:  00 PM.  
Interaction model No interaction model
parameter
estimate
SE parameter
estimate
SE
Fixed effects
Intercept 1.858 0.118 1.879 0.115
Group (treatment vs. control) 0.081 0.145 0.041 0.134
Time
Post (vs. pre) 0.162 0.067 0.097 0.049
Del (vs. pre) –0.012 0.068 –0.002 0.051
Group ! time
Group ! post –0.139 0.097
Group ! del –0.034 0.103
sin (2t/24) 0.566 0.092 0.568 0.092
cos (2t/24) –0.130 0.078 –0.128 0.078
sin (4t/24) 0.112 0.067 0.113 0.067
cos (4t/24) –0.248 0.040 –0.246 0.040
Random effects
Level 2
var(intercept) 0.086 0.032 0.085 0.032
var(sin (2t/24)) 0.057 0.028 0.058 0.029
var(cos (2t/24)) 0.003 0.011 0.002 0.011
cov(intercept, sin (2t/24)) –0.029 0.022 –0.029 0.022
cov(intercept, cos (2t/24)) –0.0002 0.013 –0.0001 0.013
cov(sin (2t/24), cos (2t/24)) –0.006 0.013 –0.006 0.013
Level 1
var(intercept) 0.192 0.013 0.193 0.013
–2 log likelihood             639.87             643.19
Research question is presented in bold.
Table 2. Parameter estimates and 
standard errors (SE) of the multilevel 
two-harmonics model to fit the
log-transformed cortisol levels in both 
the experimental group and the control 
group, at baseline (pre), after a 6-week 
treatment period (post) and after a 
6-week treatment-free period (del)
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level of 17.02 nmol/l (not shown in  fig. 1 ) was reached at 
about 5.46 AM (experimental group, post-treatment). For 
all 6 curves, the ratio of the maximum to the minimum 
cortisol levels is 4.2. The results on amplitude and peak 
time should be considered with caution because the max-
imum cortisol level has been obtained by extrapolation 
from the fitted curves.
 The mean cortisol values indicate that in  both groups 
the change in cortisol levels increased in the post-treat-
ment period and returned to their pretreatment values 
after the 6-week period without treatment (delayed mea-
surement) ( fig. 1 ,  table 2 and  3 ). We tested in this model 
the main effects of time: likelihood ratio    2  = 5.15, d.f. = 
2, p = 0.076, n.s. (post vs. pre: z = 1.99, p = 0.047; del vs. 
pre: z = –0.04, p = 0.96).
 Discussion 
 The results of the present study suggest that, in con-
trast to our expectations, high-frequency CES did not 
have a positive influence on the rest-activity rhythm and 
cortisol levels in AD patients. After the treatment (treat-
ment-free) period of 6 weeks, both the experimental and 
control group showed hardly any changes in the rest-ac-
tivity variables IS, IV and RA ( table 1 ). In addition, cor-
tisol levels in both the experimental and control group 
 increased instead of decreased after the 6-week treatment 
period and returned to pretreatment values after the 6-
week period without treatment ( table 2 and  3 ,  fig. 1 ).
 Although in the present study the lowest cortisol level 
was observed at about 9:  30 PM, an hour before and after 
that time, the cortisol level was close to this lowest point 
( fig. 1 ). These findings approach the results of an earlier 
study in which 24-hour cortisol profiles of patients with 
AD were analyzed  [23] . In that study, the lowest cortisol 
level was observed at about 8:  00 PM and remained level 
until midnight, after which the level showed a consider-
able increase. Compared to this latter finding, the level of 
salivary cortisol increased about 2 h earlier in the present 
study. One explanation might be that our patients were 
institutionalized and preparations for the night are often 
considered a stressful factor that triggers an increase in 
cortisol  [24] .
 Considering the absence of treatment effects, together 
with very small effect sizes with respect to the actigraphy 
variables IS, IV and RA and the changes in cortisol levels 
in an opposite direction, clinically relevant treatment ef-
fects cannot be expected. In other words, similar to the 
low-frequency CES study, we must conclude that also 
high-frequency CES is not effective in AD and research 
concerning its effects on circadian rhythms in AD should 
not be continued in its present form.
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Table 3. Mean cortisol levels calculated at value 0 (at 11 AM) for 
the periodic function before treatment (T1), after treatment (T2) 
and after a treatment-free period (T3)
Groups Cortisol levels
pretreatment
(T1)
post-treatment
(T2)
delayed
(T3)
Treatment 6.82 7.51 6.81
Control 6.55 7.21 6.53
Treatment is either CES (treatment group) or sham stimula-
tion (control group).
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